Search - tctmd.com

Displaying 1 - 20 of 71

Sort: Relevancy | Date

News Conference News ESC 2025

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

Caitlin E. Cox

September 05, 2025

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Conference News EuroPCR 2025

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

Yael L. Maxwell

May 23, 2025

News Daily News

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Yael L. Maxwell

January 23, 2025

Presentation TCT 2024

Debate Pro: Always

Presenter: Marco Valgimigli

October 30, 2024

Presentation TCT 2024

Sirolimus Coated Balloon Complex Cases Presentations: The TITAN RCT

Presenter: Marco Valgimigli

October 28, 2024

Presentation TCT 2024

Peri-procedural Antithrombotic Management Across Spectrum of CAD Manifestation

Presenter: Marco Valgimigli

October 28, 2024

Presentation TCT 2024

Real-Time Catheter-Based MVO Detection in STEMI: Final Results from the MOCA I Study

Presenter: Marco Valgimigli

October 27, 2024

Presentation TCT 2024

TCT 667: Real-Time Catheter-Based MVO Detection in STEMI: Final Results From the MOCA I Study

Presenter: Marco Valgimigli

October 27, 2024

Presentation TCT 2024

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

Presenter: Marco Valgimigli

October 27, 2024

News Conference News ESC 2024

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Yael L. Maxwell

September 10, 2024

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Todd Neale

September 01, 2024

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News ESC 2023

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

Todd Neale

August 26, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

Advertisement

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Debate Pro: Always

Sirolimus Coated Balloon Complex Cases Presentations: The TITAN RCT

Peri-procedural Antithrombotic Management Across Spectrum of CAD Manifestation

Real-Time Catheter-Based MVO Detection in STEMI: Final Results from the MOCA I Study

TCT 667: Real-Time Catheter-Based MVO Detection in STEMI: Final Results From the MOCA I Study

From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content